The Microbiome Therapeutics Market, 2015-2030' report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of products in this area. Imbalance in the natural microbiota are a known cause for many chronic diseases such as antibiotic associated diarrhoea (AAD), Clostridium difficile infections (CDI), irritable bowel syndrome (IBS), diabetes, Crohn's disease and ulcerative colitis.
Key Topics Covered:
- The microbiome therapeutic pipeline in terms of phase of development, type of products and indications.
- The epidemiology, patient population and available treatment plans for the potential therapeutic areas in this field.
- Partnerships that have taken place in the recent past covering research and development collaborations, product development and commercialisation agreements, license agreements, acquisitions and other relevant agreements.
- Various investments and grants received by companies focused in this area.
The study provides a detailed market forecast and opportunity analysis for the short-mid term (2015-2022) and long term (2022-2030). The research, analysis and insights presented in this report include potential sales of FMT therapies and drugs in late stages of development. Our opinions and insights, presented in this study, were influenced by several discussions we conducted with experts in this area.
Companies Mentioned Include:
- 4D Pharma
- APC Microbiome Institute
- Admera Health
- Advanced Technology Ventures
- Advancing Bio
- Assembly Biosciences
- Avid Biotics
- Whole Biome
- World Gastroenterology Organisation (WGO)
- World Health Organisation (WHO)
- Wyss Institute
- Xycrobe Therapeutics
- Yakult Honsha
2. Executive Summary
4. Microbiome Therapeutics And Diagnostics: Market Landscape
5. Probiotic And Prebiotic Drugs
6. Key Therapeutic Areas
7. Venture Capital Interest
8. Recent Collaborations
9. Market Sizing And Opportunity Analysis
10. Company Profiles
12. Interview Transcripts
13. Appendix 1: Tabulated Data
14. Appendix 2: List Of Companies And Organisations
For more information visit http://www.researchandmarkets.com/research/r5gmtc/microbiome